WILMINGTON, N.C., July 29 /PRNewswire/ -- DiaLog, Inc., a wholly owned subsidiary of Inclinix, Inc., signed a joint agreement with DeliverMed Holdings, LLC, an Illinois-based, diabetes specialty home delivery pharmacy. DiaLog's featured product, the DiaLog System, promotes compliance and adherence to blood glucose testing to help diabetic patients and their physicians better manage their disease. DeliverMed complements the DiaLog System as a leading delivery supplier of prescription medications and glucose testing supplies across the U.S.
The DiaLog System and DeliverMed's services will give physicians the single source for glucose monitoring results and prescription fulfillment information to measure patient compliance and progress. Use of the DiaLog System by DeliverMed's patients will result in enhanced compliance to prescribed therapies, improved patient outcomes and related cost savings.
The CDC recently reported nearly 24 million people in the U.S. suffer from diabetes, an increase of more than three million in two years. With this rapidly growing prevalence, it is critical to the U.S. health system to provide effective tools to better manage the disease. The DiaLog System and DeliverMed's home delivery service will provide patients a "one source" for glucose monitoring, prescription fulfillment and patient education.
Jeff Bagshaw, President of DiaLog and Senior VP of Inclinix stated, "DiaLog is a powerful, convenient system for patients and physicians to improve the quality of life for diabetic patients. The addition of DeliverMed to the DiaLog system will allow us to provide easily accessible prescription drugs and supplies to diabetics."
Founded in 1998, DeliverMed provides prescription medications and glucose testing supplies to the homes of individuals suffering from diabetes and other chronic conditions. DeliverMed combines the latest in pharmacy robotic technology with old-fashioned personal customer service to provide the highest quality patient care. DeliverMed provides its services at no additional cost to either patients or insurers. For more information on DeliverMed, contact CEO, Mark A. Swift.
Founded in 1999, Inclinix provides strategic medical marketing
communications and adherence services to the healthcare industry. Inclinix
delivers customized marketing solutions that yield improved market
penetration and adherence results. In the pharmaceutical development arena,
Inclinix is a contract research organization that supports and manages
clinical drug trials and patient recruitment. For more information about
Inclinix, visit http://www.inclinix.com .
Mark A. Swift
Chief Executive Officer
Senior VP of Inclinix
|SOURCE Inclinix, Inc.|
Copyright©2008 PR Newswire.
All rights reserved